依据美国肿瘤联合委员会(American Joint Committee on Cancer,AJCC)第8版TNM分期系统,T4期结肠癌分为肿瘤穿透脏层腹膜(T4a期)、肿瘤直接侵犯或附着于邻近器官和结构(T4b期)2类[4]。对于非转移性T4期结肠癌病人,根治性手术切除是治疗的主...
肿瘤已侵入胃壁的最外层（浆膜）。1-6个区域淋巴结有转移。（T4a，N1或N2，M0）肿瘤已通过胃壁发展至...
TNM 分期表进行临床分期时,可采用先 M、再 N、后 T 的方法。 先看M 分期—— 若为 M1a 或 M1b,则不需看 T 和 N,直接归为 ⅣA 期;若为 M1c,也不需看 T 和 N,直接归为 ⅣB 期;若为 M0,则需要去看 T 和 N。 再看N 分期(M0 情况下) —— 若为 N1,任何 T1 或 T2 均归为 ⅡB 期...
We sought to determine long-term conditional PCSM for patients with stage T4, N1, or M1 prostate cancer. We identified 66,817 patients diagnosed with stage IV (T4N0M0, N1M0, or M1) prostate cancer between 1973 and 2011 using the Surveillance, Epidemiology, and End Results (SEER) database...
● 扩散到淋巴结程度增加,依次用N1-N2表示。 M:表示远端转移的程度。 ● 没有远处转移为M0; ● 有远处转移为M1; ● 转移局限于单个器官的为M1a; ● 转移多个器官的为M1b; ● 腹膜转移有或没有其他器官转移的为M1c。 对于结直肠癌来说,根据结直肠癌扩散程度一般分为0期、I期、II期、III期和IV期。
Adjuvant Treatment is Superior to Salvage Therapy for Pathological T2-3N0M0 or T1-4N1M0/T4N0M0 Esophageal Cancer after Radical Surgerydoi:10.1016/j.ijrobp.2017.06.1022Ni, W.Yang, J.Xiao, Z.Wang, X.Zhou, Z.Zhang, H.Chen, D.Feng, Q....
Radiation Oncology (2022) 17:126 https://doi.org/10.1186/s13014-022-02080-9 RESEARCH Open Access Long‑term survival of patients with central or > 7 cm T4 N0/1 M0 non‑small‑cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to ...
T4 extension alone is more predictive of better survival than a tumour size > 7 cm for resected T4N0-1M0 non-small-cell lung cancer 来自 掌桥科研 喜欢 0 阅读量: 7 作者: Li, QiuyuanZhang, PengWang, YiLiu, DanLuo, LeiDiasio, Robert B.Yang, PingJiang, Gening 摘要: OBJECTIVES T4N0...
The Optimal Treatment Modality in Patients with T4N2M0 Non-Small Cell Lung Cancer: The Best Choice May Be Definitive Chemoradiotherapy Followed by Consolid... The optimal treatment modality in patients with T4N2M0 non-small cell lung cancer:the best choice may be definitive chemoradiotherapy ...